Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

November 29, 2017 Leave a comment 3,669 Views

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Cosine

Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

Single-cell CUT&Tag to identify cell states in normal and disease tissue

The triumphs and limitations of computational methods for scRNA-seq

Researchers have assembled the most comprehensive RNA-atlas ever

More evidence that most cancer cells grown in a dish have little in common transcriptionally with cancer cells in people

SuperFreq – detecting copy number alterations in RNA-Seq using

RNA sequencing identifies trigger for ‘head-to-tail’ axis development in human embryo

How long-known genes continue to surprise researchers